Victoria Yorke-Edwards
Overview
Explore the profile of Victoria Yorke-Edwards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gorrod H, Mt-Isa S, Xuan J, Vandormael K, Malbecq W, Yorke-Edwards V, et al.
Stat Methods Med Res
. 2025 Jan;
34(2):322-335.
PMID: 39819221
Treatment switching is common in randomised controlled trials (RCTs). Participants may switch onto a variety of different treatments, all of which may have different treatment effects. Adjustment analyses that target...
2.
Xuan J, Mt-Isa S, Latimer N, Gorrod H, Malbecq W, Vandormael K, et al.
Stat Methods Med Res
. 2024 Dec;
34(2):286-306.
PMID: 39668583
Deviation from the treatment strategy under investigation occurs in many clinical trials. We term this intervention deviation. Per-protocol analyses are widely adopted to estimate a hypothetical estimand without the occurrence...
3.
Taheri S, Yorke-Edwards V, Sydes M, Isaacs T, Love S
Trials
. 2024 Nov;
25(1):748.
PMID: 39516824
Background: Monitoring is a crucial part of trial conduct and ensures that participants' data is fairly represented, and future healthcare information is enhanced. This project aims to improve trial monitoring...
4.
Sydes M, Murray M, Ahmed S, Apostolidou S, Bliss J, Bloomfield C, et al.
Contemp Clin Trials
. 2024 Mar;
141:107514.
PMID: 38537901
Background: Better use of healthcare systems data, collected as part of interactions between patients and the healthcare system, could transform planning and conduct of randomised controlled trials. Multiple challenges to...
5.
Yorke-Edwards V, Diaz-Montana C, Murray M, Sydes M, Love S
Res Methods Med Health Sci
. 2023 Oct;
4(4):124-135.
PMID: 37795045
Background: Over the last decade, there has been an increasing interest in risk-based monitoring (RBM) in clinical trials, resulting in a number of guidelines from regulators and its inclusion in...
6.
Hsieh S, Yorke-Edwards V, Murray M, Diaz-Montana C, Love S, Sydes M
Clin Trials
. 2023 Jan;
20(2):121-132.
PMID: 36629015
Background: Monitoring is essential to ensure patient safety and data integrity in clinical trials as per Good Clinical Practice. The Standard Protocol Items: Recommendations for Interventional Trials Statement and its...
7.
Love S, Yorke-Edwards V, Ward E, Haydock R, Keen K, Biggs K, et al.
Trials
. 2022 Oct;
23(1):836.
PMID: 36183080
Background: The sources of information on clinical trial monitoring do not give information in an accessible language and do not give detailed guidance. In order to enable communication and to...
8.
Love S, Kilanowski A, Yorke-Edwards V, Old O, Barr H, Stokes C, et al.
Trials
. 2021 Sep;
22(1):654.
PMID: 34565428
Background: A promising approach to reduce the increasing costs of clinical trials is the use of routinely collected health data as participant data. However, the quality of this data could...
9.
Love S, Yorke-Edwards V, Diaz-Montana C, Murray M, Masters L, Gabriel M, et al.
Clin Trials
. 2021 Mar;
18(3):386-388.
PMID: 33653161
No abstract available.
10.
Cragg W, Hurley C, Yorke-Edwards V, Stenning S
Clin Trials
. 2021 Feb;
18(2):245-259.
PMID: 33611927
Background/aims: It is increasingly recognised that reliance on frequent site visits for monitoring clinical trials is inefficient. Regulators and trialists have recently encouraged more risk-based monitoring. Risk assessment should take...